Latest
Diseases & Illness
& Related Newswire
6/21/2006 5:29:00 AM | Watchdog setback for inhaled insulin 
=(0) There is now an alternative for diabetics who need to inject insulin: a form of the medication that can be inhaled, called Exubera. It has been approved in Europe and the US, but regulators in Britain are throwing up roadblocks to its use. The National Institute for Health and Clinical Excellence does not find Exubera to be cost-effective and ...
Read More
6/20/2006 9:53:00 AM | Cancer cases may be linked to exhaust, customs officers fear =(0) Border guards at the Canada-US border between Windsor Ontario and Detroit are concerned about the effect of breathing diesel fumes. Seven cases of breast cancer in female guards have been found in the last five years, and many others have respiratory symptoms and lung damage evident on chest x-rays. The guards' union has called for a study to ...
Read More
6/19/2006 7:12:00 PM | Study Spots Potential Stroke Drugs =(0) A drug type currently used to treat heart disease may also be useful for early treatment of stroke victims, according to Duke University researchers. Cardiac glycosides increase calcium levels in cells, which guards against cell death. Stroke and heart disease can alter cell calcium concentration. While the research has not yet even been ...
Read More
6/19/2006 5:23:00 PM | Diabetes vaccine mechanism found =(0) There is a vaccine in development for type I (juvenile) diabetes. It has proven successful in stopping the progression of the disease in lab animals, and is now in clinical trials. It works by stopping the autoimmune response with a particular protein called HSP60. Recent research has revealed how the vaccine works on a molecular level, a...
Read More
6/19/2006 1:46:00 PM | Chronic Fatigue Syndrome - a hidden killer =(0) A woman in Britain has become the first fatality attributed to Chronic Fatigue Syndrome. The cause of death was dehydration leading to kidney failure, but doctors say the reason for the dehydration was because she was too fatigued to drink. Chronic Fatigue is a recognized condition that tends to occur after a viral infection, often in com...
Read More
6/19/2006 11:18:00 AM | Asbestos victims' long search for justice =(0) This is an overview of the ideas behind the current mesothelioma compensation legal debate in Britain. The basic question is, if an employee worked for more than one company and ultimately developed disease, which, if any, of the companies are responsible, and in what proportion? A recent legal ruling apportioned compensation according to...
Read More
6/18/2006 11:55:00 PM | Iron Content in Formula and Parkinson's Disease =(0) Researchers are now studying the effect of iron supplements given to pregnant mothers and newborns. The suspicion is that the recommended dose is too high. Studies on mice suggest that iron added to infant formula in too great an amount may be linked to later development of Parkinson's Disease. Excess iron is thought to cause oxidative st...
Read More
6/18/2006 8:08:00 AM | Stroke risk spikes with diabetes diagnoses =(0) An analysis of data by Canadian researchers shows that health risks caused by type II diabetes occur earlier than previously thought. The risks of stroke, heart attack and kidney failure rise upon onset of the disease, not slowly in the long term. Researchers say this implies that damage to blood vessels happens quickly and that diabetic...
Read More
6/17/2006 5:51:00 AM | Lanxess: Cancer study flawed =(0) A town just west of Cincinnati has been found to have a higher than normal incidence of lung, mouth and colorectal cancer; however a local chemical plant denies implications that its pollution is the cause. The EPA has cited the company, Lanxess, for pollution; Lanxess claims that the state is using outdated science and that its discharges are...
Read More
6/17/2006 1:16:00 AM | Court: Wrongful death trial can resume with 11 jurors =(0) The trial in a wrongful death lawsuit against ExxonMobil may resume with only 11 jurors, according to the Louisiana Supreme Court. The suit concerns the death of a worker whose job it was to chip asbestos off of pipes. James Terrance later died of mesothelioma, a lung cancer known to be caused by asbestos exposure. One of the original jur...
Read More
6/16/2006 1:13:00 AM | State court to handle roughly 60 Novartis suits =(0) More than 60 pending lawsuits against drugmaker Novartis have been moved to a US District Court in Tennessee. The suits claim that the drugs Aredia and Zometa, both made by Novartis, caused them to suffer "jaw death" or osteonecrosis of the jaw. The plaintiffs claim that Novartis did not sufficiently warn doctors about this possibility. The en...
Read More
6/14/2006 7:22:00 PM | Early warning hope for diabetes =(0) Researchers are working on a blood test to identify those at high risk of developing type II diabetes. They have identified a protein, RPB4, whose levels are increased in people with insulin resistance. It is suspected that the protein might be the cause of insulin resistance in cells, but no matter what the association, it may be a reliable i...
Read More
6/14/2006 4:18:00 PM | Baylor University Researchers Develop Promising Treatment for Type ... =(0) Baylor University researchers have succeeded in delivering human insulin genes into the pancreas of rats, with the effect of lowering the animal's blood sugar. The technique involves encasing the genes in microbubbles, which are burst with ultrasound when they reach the pancreas. If a similar technique is successful in humans it could mea...
Read More
6/14/2006 11:20:00 AM | Ruling: WR Grace executives did not knowingly endanger Libby ... =(0) Part of the indictment against W.R. Grace & Co. on asbestos-related issues was dismissed on the grounds that the statute of limitations had run out. The charge of consipiracy, that is, knowingly endangering workers and residents, has a five year limit. The company operated a vermiculite mine in Libby, Montana until 1990. It was later disc...
Read More
6/14/2006 9:29:00 AM | Researchers Revisit Radiation After Lung Cancer Surgery =(0) Patients with lung cancer who have surgery may benefit from radiation therapy after their operations, according to new research. In one study, five year survival was 7% higher in patients given radiation after surgery, than in patients who only had surgery. Currently, surgery is generally followed by chemotherapy. Radiation had been used...
Read More
6/14/2006 1:42:00 AM | Vaccine for lung cancer sufferers =(0) A vaccine for lung cancer is in development. It would work by causing the immune system to fight a specific protein that forms on the surface of non-small cell lung cancer tumors, a common form of lung cancer. It is hoped the vaccine would be available in the next few years. .........
Read More
6/13/2006 10:14:00 PM | Breast Cancer, Osteoporosis And Bone Cancer Treatment Drugs May ... =(0) Patients and doctors need to be aware of the risks of biphosphonate drugs such as Fosamax. These drugs are widely prescribed for osteoporosis and some cancers because they slow down the process of bone cell removal and allow bone cells to last longer. However when the patient undergoes some dental procedures such as tooth extractions or other ...
Read More
6/13/2006 9:34:00 PM | Patient Learns His Operation Wasn't Sterile =(0) A San Diego hospital, Scripps Green Hospital, has been notifying 82 patients who are at risk of having contracted infections because of inadequately sterilized surgical equipment. This exposes patients to potential infections such as HIV and hepatitis. The hospital is providing blood tests and follow-up, but the patient interviewed for th...
Read More
6/13/2006 2:38:00 PM | Experimental Drugs Help Reduce Effects Of Stroke =(0) An experimental program in Washington DC is testing a new combination of clot-busting drugs for stroke victims. The drugs are useful up to 24 hours after the onset of a stroke, instead of the 3 hours for current medications - when they are even available. The program has treated 36 patients so far. One of their stories is described in the...
Read More
6/13/2006 2:27:00 PM | Novartis, Merck collaborate on new diabetes drug =(0) A new class of drugs for type II diabetes is under development by Merck and Novartis. The drugs, known as DPP-4 inhibitors, are meant to stimulate certain hormones that control glucose metabolism. Both Merck's Januvia and Novartis' Galvus worked well in clinical trials and had fewer side effects than current diabetes medications. Bot...
Read More
Diseases & Illness News 1 | Diseases & Illness News 2 | Diseases & Illness News 3 | Diseases & Illness News 4 | Diseases & Illness News 5 | Diseases & Illness News 6 | Diseases & Illness News 7 | Diseases & Illness News 8 | Diseases & Illness News 9 | Diseases & Illness News 10 | Diseases & Illness News 11